Rafael Holdings Inc. (NYSE: RFL) completed the final patient visit for its pivotal Phase 3 TransportNPC study evaluating Trappsol Cyclo ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE